Results 271 to 280 of about 4,368,112 (356)
Secondary hypertension and aortic coarctation in a young adult: A case report. [PDF]
Reis D, Gomes T, Teixeira A, Martins C.
europepmc +1 more source
Clinical Effect of Renal Arterial Sympathetic Radiofrequency Ablation on Secondary Hypertension.
Zhang H +6 more
europepmc +1 more source
Objective Dotinurad is a selective urate reabsorption inhibitor that reduces serum urate levels. We compared the efficacy and safety of dotinurad with febuxostat in Chinese patients with gout. Methods This phase 3, multicenter, randomized, double‐blind, parallel‐group study randomly allocated (1:1) eligible patients with gout to receive oral dotinurad ...
Jia Sun +19 more
wiley +1 more source
Beta-2 Glycoprotein I IgA Isotype: An Important Consideration in Secondary Hypertension. [PDF]
Fusillo TF, Capicotto L, Gill J.
europepmc +1 more source
Sildenafil attenuates pulmonary vascular remodeling and upregulates Kv1.5 mRNA expression in pulmonary hypertension secondary to left-to-right shunt in rats [PDF]
Lei Hu, LH Tan
openalex +1 more source
Objective International criteria for antiphospholipid syndrome (APS) include lupus anticoagulant (LA), anticardiolipin (aCL) immunoglobulin (Ig) G and IgM, and anti‐β2‐glycoprotein I (β2GPI) IgG and IgM. However, evidence supporting their prognostic value or treatment efficacy in improving live birth rates is limited.
Megumi Nonobe +8 more
wiley +1 more source
Ambulatory isolated diastolic hypertension and risk of left ventricular hypertrophy in children with primary and secondary hypertension. [PDF]
Myette RL +5 more
europepmc +1 more source
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane +33 more
wiley +1 more source

